"Mobile Heart Specialists, P.C. offers complete cardiac services. This includes management of general adult cardiology problems, coronary artery and peripheral artery diagnosis and treatment, cardiac rhythm management (ablation procedures, implantable defibrillators and pacemakers), as well as a full non-invasive diagnostic lab."

During the past decade, Mobile Heart Specialists, PC conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mobile Heart Specialists, PC" #1 sponsor was "Forest Laboratories" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Anthera Pharmaceuticals" with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mobile Heart Specialists, PC" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator and "Cardiokine Biopharma, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Mobile Heart Specialists, PC" are "Atrial Fibrillation" (6 trials), "Heart Failure" (4 trials), "Congestive Heart Failure" (3 trials), "Atrial Flutter" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Mobile Heart Specialists, PC" in a lesser frequency.

Most popular intervention types in "Mobile Heart Specialists, PC" are "Drug" (22 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Azimilide Dihydrochloride" (3 trials), "A-002" (2 trials), "Apixaban" (2 trials) and "Empagliflozin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mobile Heart Specialists, PC" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Mobile Heart Specialists, PC". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Mobile Heart Specialists, PC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Mobile Heart Specialists, PC, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".